Outcomes and patterns of infections in patients with underlying haematological malignancies admitted to intensive care
Editor-We read with interest the article by Bird and colleagues 1 'Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study'. Patients with haematological malignancies admitted to an intensive care unit (ICU) with an acute illness have experienced significantly improved outcome in recent years, in comparison with observed hospital mortality rates of up to 80% in the 1980s in those developing respiratory failure. 2 The current paper provides further credence to this observation reporting spectacular survival rates in acutely ill haematology patients admitted to ICU.
1 Despite significant improvement in the last few decades, high risk of death still exists in those requiring multiple organ support, and those who do survive have a long recovery time, including prolonged ICU and hospital lengths of stay (LOS).
In a retrospective and parallel study recently conducted in our own ICU in a tertiary referral centre for haematological diseases in London, UK, we audited outcomes of acutely ill haematology patients admitted to our ICU. The audit was part of a service evaluation for which local R&D approval was obtained. In addition to survival outcome, we extended our query to study the patterns of infections seen in acutely ill haematology patients in our ICU that is unlike previously published studies, which studied infections in a non-critically ill haematology patient population.
All consecutive admissions of adult patients to the ICU with an underlying haematological malignancy between January 2005 and December 2008 were included. The data collection involved information obtained from the ICU and the Pathology databases, with a senior haematologist independently verifying the haematological details.
Ninety-seven out of the total 3880 (3%) patients admitted to ICU during the study period had an identifiable underlying haematological malignancy. Fifty-seven per cent were males, and the median age was 53 (IQR¼37-62) yr. The haematological diagnoses included non-Hodgkin's lymphoma (28%), acute myeloid leukaemia (27%), acute lymphoblastic leukaemia (11%), Hodgkin's lymphoma (10%), and others (24%). Twenty-eight per cent of the patients had previously received haematopoetic stem cell transplantation (HSCT), 81% allogeneic and 19% autologous, and 36% patients had recent chemotherapy (within 4 weeks of ICU admission). Six patients also had human immunodeficiency virus disease.
Acute respiratory failure (45%), systemic sepsis (24%), neurological (10%), and cardiac illness (7%) accounted for acute decompensation and admission to ICU, with a median APACHE II score of 25 (IQR¼22 -30) representing severe acuity of illness. Forty-two per cent were neutropenic (neutrophils ≤1×10 9 litre 21 ) at admission. Invasive mechanical ventilation was required in the majority of patients (73%), and renal support in 39%. The presence of infection was identified in 69 out of the 97 patients (71%); 56 had confirmed infection and 13 were presumed to have an infection on clinical grounds. One, two, or three types of organism were identified in 32, 15, and 6 patients, respectively. Coagulase-negative Staphylococcus (n¼21), Pseudomonas aeruginosa (n¼15), and Enterococcus (n¼14) were the most frequent bacterial isolates, others being Escherichia coli (n¼6), Stenotrophomonas maltophilia (n¼6), Klebsiella sp. (n¼5), Acinetobacter sp. (n¼5), and Staphylococcus aureus (n¼3). Cytomegalovirus (CMV), Human Herpes Virus 6 (HHV6), and Epstein-Barr virus (EBV) were identified in 17, 5, and 5 patients, respectively, while fungal infection with Candida species were present in six patients.
The overall ICU and hospital mortality and the corresponding LOS were 52% and 64%, and 8 (IQR¼3-15) and 39 (IQR¼23-59) days. Invasive mechanical ventilation as the sole organ support was associated with an ICU mortality of 39%, but in combination with renal support, the mortality was 94%.
None of the infection-related characteristics was associated with increased ICU or in-hospital mortality. However, identification of an infectious pathogen with increasing number of identified organisms and identifying a viral pathogen, particularly CMV, were associated with significantly longer ICU and hospital stay (Table 1) . CMV infection is one of the most common complications of allogeneic stem cell transplants 3 and CMV viraemia is commonly complicated by co-infection. 4 5 In the cohort of patients admitted to our ICU, 41% of the patients who were CMV DNA-positive were allogeneic SCT recipients and 29% had bacterial co-infection. While previous HSCT overall was not associated with increased risk of infective complications at admission, all autologous HSCT patients had documented or suspected infection at admission. A recent publication 4 highlighted that CMV infection is more common in patients with haematological malignancies than previously thought, especially in patients receiving rituximab and steroids. The significance of the presence of CMV viraemia and other viral infections such as EBV and HHV6 in the non-transplant group remains unclear, and whether routine investigation and treatment of these infections in the non-BMT group leads to clinical benefit needs further investigation. Nevertheless, it is now being recognized that the risk of CMV infection and routine prophylaxis even in immunocompetent patients may have a role in the overall outcome of acutely ill patients. The currently ongoing study 'Anti-viral prophylaxis for prevention of CMV reactivation in immunocompetent patients in critical care' (UKCRN ID 11642) may provide answers in the near future. Our results, particularly the prognostic factors influencing mortality, are broadly similar to the findings of Bird and colleagues, 1 except that our survival rates are not as impressive.
This may be because of a greater severity of illness in our patient group (APACHE score 25 vs 21) and a slightly different patient mix in terms of haematology diagnoses. In summary, most patients with haematological malignancies admitted to intensive care have a clinically suspected or documented infectious cause and although infection characteristics do not appear to be associated with overall mortality, they are associated with prolonged ICU and hospital length of stay.
